Emami Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 4/6

Emami yıllık ortalama 18.2% oranında kazançlarını artırırken, Personal Products sektöründe kazançlar growing at 10.1% annual. Gelirler growing yılda ortalama 7.4% oranında artmaktadır. Emami'in özkaynak karlılığı 29.3% ve net marjı 21%'dir.

Anahtar bilgiler

18.2%

Kazanç büyüme oranı

18.9%

EPS büyüme oranı

Personal Products Sektör Büyümesi	7.9%
Gelir büyüme oranı	7.4%
Özkaynak getirisi	29.3%
Net Marj	21.0%
Son Kazanç Güncellemesi	30 Sep 2024

Yakın geçmiş performans güncellemeleri

Recent updates

These 4 Measures Indicate That Emami (NSE:EMAMILTD) Is Using Debt Reasonably Well

Feb 27

Emami (NSE:EMAMILTD) Is Due To Pay A Dividend Of ₹4.00

Feb 09

Here's Why We Think Emami (NSE:EMAMILTD) Might Deserve Your Attention Today

Feb 04

Emami's (NSE:EMAMILTD) Dividend Will Be ₹4.00

Nov 18

Emami (NSE:EMAMILTD) Seems To Use Debt Quite Sensibly

Nov 13

With EPS Growth And More, Emami (NSE:EMAMILTD) Makes An Interesting Case

Oct 24

Is Now An Opportune Moment To Examine Emami Limited (NSE:EMAMILTD)?

Sep 27

We Ran A Stock Scan For Earnings Growth And Emami (NSE:EMAMILTD) Passed With Ease

Jul 26

Emami (NSE:EMAMILTD) Could Easily Take On More Debt

Jul 08

Is Now The Time To Put Emami (NSE:EMAMILTD) On Your Watchlist?

Apr 14

Is Emami (NSE:EMAMILTD) Using Too Much Debt?

Mar 24

Emami (NSE:EMAMILTD) Has Affirmed Its Dividend Of ₹4.00

Feb 06

Should You Investigate Emami Limited (NSE:EMAMILTD) At ₹486?

Jan 19

Is Emami (NSE:EMAMILTD) A Risky Investment?

Dec 13

If You Like EPS Growth Then Check Out Emami (NSE:EMAMILTD) Before It's Too Late

Nov 25

Is There Now An Opportunity In Emami Limited (NSE:EMAMILTD)?

Oct 21

Is Emami (NSE:EMAMILTD) Using Too Much Debt?

Sep 08

Here's Why I Think Emami (NSE:EMAMILTD) Is An Interesting Stock

Aug 20

Why Emami Limited (NSE:EMAMILTD) Could Be Worth Watching

Jul 16

Is Emami (NSE:EMAMILTD) A Risky Investment?

Jun 09

Here's Why I Think Emami (NSE:EMAMILTD) Might Deserve Your Attention Today

May 21

Is It Time To Consider Buying Emami Limited (NSE:EMAMILTD)?

Apr 04

Gelir ve Gider Dağılımı

Emami nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

NSEI:EMAMILTD Gelir, gider ve kazançlar (INR Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri
30 Sep 24	36,842	7,726	11,031
30 Jun 24	36,585	7,385	10,893
31 Mar 24	35,781	7,235	10,591
31 Dec 23	35,228	7,191	10,103
30 Sep 23	35,092	6,978	9,892
30 Jun 23	34,581	7,035	9,681
31 Mar 23	34,057	6,396	9,399
31 Dec 22	33,428	8,511	9,419
30 Sep 22	33,311	8,339	9,258
30 Jun 22	33,094	8,350	8,714
31 Mar 22	31,872	8,390	8,475
31 Dec 21	31,524	5,707	8,280
30 Sep 21	31,142	5,597	8,294
30 Jun 21	30,601	4,929	8,238
31 Mar 21	28,805	4,547	7,720
31 Dec 20	26,825	3,903	7,346
30 Sep 20	25,615	3,257	7,157
30 Jun 20	24,876	3,033	7,022
31 Mar 20	26,549	3,029	7,779
31 Dec 19	27,609	3,357	7,767
30 Sep 19	27,593	3,292	7,625
30 Jun 19	27,272	3,158	7,532
31 Mar 19	26,946	3,032	7,598
31 Dec 18	26,703	3,073	7,496
30 Sep 18	26,162	3,168	7,480
30 Jun 18	26,161	3,328	7,420
31 Mar 18	25,305	3,071	7,343
31 Dec 17	24,875	3,302	7,039
30 Sep 17	24,446	3,174	6,845
30 Jun 17	23,887	2,848	6,881
31 Mar 17	24,882	3,404	6,847
31 Dec 16	27,855	3,347	8,029
30 Sep 16	27,849	3,347	8,003
30 Jun 16	27,310	3,291	7,850
31 Mar 16	23,583	3,635	6,454
31 Dec 15	25,067	4,215	8,092
30 Sep 15	24,104	4,711	7,671
30 Jun 15	23,254	5,025	7,373
31 Mar 15	22,172	4,856	5,659
31 Dec 14	21,093	4,584	6,296
30 Sep 14	20,017	4,254	5,895
30 Jun 14	19,189	4,126	5,595
31 Mar 14	18,208	4,025	5,211
31 Dec 13	18,316	3,853	5,054

Kaliteli Kazançlar: EMAMILTD yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: EMAMILTD 'nin mevcut net kar marjları (21%) geçen yılın (19.9%) sinden daha yüksektir.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: EMAMILTD şirketinin kazancı son 5 yılda yılda 18.2% oranında arttı.

Büyüme Hızlandırma: EMAMILTD 'un son bir yıldaki kazanç büyümesi ( 10.7% ) 5 yıllık ortalamasının ( 18.2% /yıl) altındadır.

Kazançlar vs. Sektör: EMAMILTD geçen yılki kazanç büyümesi ( 10.7% ) Personal Products sektörünün 22.8% performansını geride bırakmadı.

Özkaynak Getirisi

Yüksek ROE: EMAMILTD 'nin Özsermaye Getirisi ( 29.3% ) yüksek olarak değerlendiriliyor.

Emami Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 4/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

Second quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behind

Emami Limited to Report Q2, 2025 Results on Nov 07, 2024

First quarter 2025 earnings: EPS misses analyst expectations

Emami Limited to Report Q1, 2025 Results on Aug 01, 2024

Full year 2024 earnings released: EPS: ₹16.55 (vs ₹14.50 in FY 2023)

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Recent updates

Price target decreased by 7.2% to ₹805

Emami (NSE:EMAMILTD) Has Announced A Dividend Of ₹4.00

First half dividend of ₹4.00 announced

Second quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behind

Emami Limited to Report Q2, 2025 Results on Nov 07, 2024

Price target increased by 8.4% to ₹778

Emami Limited, Annual General Meeting, Aug 27, 2024

First quarter 2025 earnings: EPS misses analyst expectations

What Is Emami Limited's (NSE:EMAMILTD) Share Price Doing?

Emami Limited to Report Q1, 2025 Results on Aug 01, 2024

Is Emami (NSE:EMAMILTD) Using Too Much Debt?

Emami Limited's (NSE:EMAMILTD) 35% Price Boost Is Out Of Tune With Earnings

Investor sentiment improves as stock rises 33%

Price target increased by 8.2% to ₹613

Emami (NSE:EMAMILTD) Ticks All The Boxes When It Comes To Earnings Growth

Full year 2024 earnings released: EPS: ₹16.55 (vs ₹14.50 in FY 2023)

Emami Limited (BSE:531162) signed a share purchase agreement to acquire 4.64% stake in Brillare Science Pvt. Ltd. from founder and other shareholders of Brillare Science Pvt. Ltd.

Is There Now An Opportunity In Emami Limited (NSE:EMAMILTD)?

Dividend of ₹4.00 announced

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Emami Limited Approves Second Interim Dividend for the Financial Year 2023-24

Investor sentiment improves as stock rises 16%

Emami (NSE:EMAMILTD) Seems To Use Debt Rather Sparingly

Emami (NSE:EMAMILTD) Has Affirmed Its Dividend Of ₹4.00

Emami Limited Declares Interim Dividend for the Financial Year 2023-24

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Emami Limited (BSE:531162) completed the acquisition of 26% stake in Axiom Ayurveda Private Limited

Emami Limited (BSE:531162) entered into definitive agreement to acquire 26% stake in Axiom Ayurveda Private Limited.

Emami Limited Announces Change in Management

Manipal Health Enterprises Pvt Ltd acquired 84% stake in AMRI Hospitals Ltd. from Emami Limited (BSE:531162).

Manipal Health Enterprises Pvt Ltd acquired 84% stake in AMRI Hospitals Ltd. from Emami Limited (BSE:531162).

Emami Limited Announces Changes to the Senior Management Personnel

Insider recently bought ₹1.0m worth of stock

Emami May Seal AMRI Sale to Manipal Group This Month

Price target increased by 7.6% to ₹517

Emami Limited Announces Cessation of Mr. Vinod Rao, President-CCD, Personnel of Senior Management Effective from the Closing Hours of July 31, 2023

Is Now The Time To Look At Buying Emami Limited (NSE:EMAMILTD)?

Full year 2023 earnings: EPS misses analyst expectations

Emami Limited to Report Q4, 2024 Results on May 30, 2024

Emami Limited Proposes Two Interim Dividends for the Financial Year 2022-23

Emami Limited, Annual General Meeting, Aug 23, 2023

Does Emami (NSE:EMAMILTD) Have A Healthy Balance Sheet?

Emami Limited to Report Q1, 2024 Results on Aug 07, 2023

Emami Limited Approves Executive Changes

Full year 2023 earnings: EPS misses analyst expectations

What Is Emami Limited's (NSE:EMAMILTD) Share Price Doing?

These 4 Measures Indicate That Emami (NSE:EMAMILTD) Is Using Debt Reasonably Well

Emami (NSE:EMAMILTD) Is Due To Pay A Dividend Of ₹4.00

Price target decreased by 7.3% to ₹510

Third quarter 2023 earnings: EPS exceeds analyst expectations

Emami Limited Declares Second Interim Dividend for the Financial Year 2022-23

Here's Why We Think Emami (NSE:EMAMILTD) Might Deserve Your Attention Today

Emami Limited to Report Q3, 2023 Results on Feb 03, 2023

Max Healthcare Reportedly Eyeing AMRI Hospitals

Emami's (NSE:EMAMILTD) Dividend Will Be ₹4.00

Second quarter 2023 earnings: EPS exceeds analyst expectations

Emami (NSE:EMAMILTD) Seems To Use Debt Quite Sensibly

Second quarter 2023 earnings: EPS exceeds analyst expectations

Emami Limited Declares Interim Dividend for the Financial Year 2022-23

With EPS Growth And More, Emami (NSE:EMAMILTD) Makes An Interesting Case

Emami Limited to Report Q2, 2023 Results on Nov 11, 2022

Is Now An Opportune Moment To Examine Emami Limited (NSE:EMAMILTD)?

Emami Limited, Annual General Meeting, Sep 09, 2022

First quarter 2023 earnings released: EPS: ₹1.67 (vs ₹1.75 in 1Q 2022)

We Ran A Stock Scan For Earnings Growth And Emami (NSE:EMAMILTD) Passed With Ease

Emami Limited (BSE:531162) acquired 30% stake in Cannis Lupus Services India Private Limited.

Emami Limited to Report Q1, 2023 Results on Jul 29, 2022

Emami (NSE:EMAMILTD) Could Easily Take On More Debt

Full year 2022 earnings: EPS exceeds analyst expectations